Our medium-term business plan, value creation process, and material issues to be addressed.
  • Medium-Term Business Plan STS2030 Revision(FY2023 – FY2030)

    Under the plan’s vision – Building Innovation Platforms to Shape the Future of Healthcare– the Group is making a concerted effort to achieve the business plan.

  • Value Creation Model

    View our value creation process. By sustaining this process, we aim to continue increasing the Group’s various management capitals to maximize the corporate value of the Shionogi Group.

  • Materiality

    View our material issues (materiality) and the assessment process.